Comparison of Effectiveness of Tonic, High Frequency and Burst Spinal Cord Stimulation in Chronic Pain Syndromes
NCT ID: NCT03957395
Last Updated: 2019-05-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2018-09-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The efficacy of SCS in different modes of stimulation is evaluated. Patients receive four different types of stimulation for 2-week period - not knowing what kind of stimulation it is. It is said that in one type of stimulation they would feel parestesias and in other three they would not. Patients are not informed that beside tonic, burst and high frequency stimulation, the fourth is an off stimulation to check for placebo effect. The test is double-blinded
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Spinal Cord Burst Stimulation for Chronic Radicular Pain Following Lumbar Spine Surgery
NCT03546738
Effects of taVNS on Postoperative Pain in Complex Spinal Surgery
NCT07330973
Evaluation of the Efficacy of STNS With FAST and MULTIWAVE in Patients With Refractory Chronic Neuropathic Pain
NCT07154056
Subcutaneous Nerve Stimulation for Failed Back Surgery Syndrome (FBSS) Patients
NCT01818297
Patient Preference and Long-term Outcomes in Persistent Spinal Pain Syndrome: A Prospective Study Comparing Spinal Cord Stimulation to Intrathecal Drug Delivery.
NCT07091123
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All patients undergo percutaneus (1 or 2) 8-contact SCS electrode implantation with trial.
All patients are blindly randomized to tonic or burst or high frequency or off stimulation. After 2-week period each participant is adequately switched to another type of stimulation for next 2 weeks. Alltogether crossover takes 8 weeks: four 2-week periods of tonic, burst, HF and off stimulation. At the end of trial period patients are subjected to the mode of stimulation which is the most efficent. The final 2-week stimulation is performed with final renewed evaluation for VAS, amount of taken medications, dissability scale, Quality of Life (QoL), sleep disorders and mental disorders. Follow-up observation will last up to 12 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
scs high-frequency
high-frequency stimulation
Device: Precision Novi™ system Neurostimulation procedures
SCS with Device: Precision Novi™ system
scs tonic
tonic stimulation
Device: Precision Novi™ system Neurostimulation procedures
SCS with Device: Precision Novi™ system
scs burst
burst stimulation
Device: Precision Novi™ system Neurostimulation procedures
SCS with Device: Precision Novi™ system
scs off
off stimulation
Device: Precision Novi™ system Neurostimulation procedures
SCS with Device: Precision Novi™ system
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Device: Precision Novi™ system Neurostimulation procedures
SCS with Device: Precision Novi™ system
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Chronic pain as a result of FBSS that exists for at least 6 months
3. ≥ 18 years of age
4. Written consent of the patient to participate in study procedures.
Exclusion Criteria
2. Addiction to any of the following: drugs, alcohol and/or medication
3. Evidence of an active disruptive psychiatric disorder or other known condition significant enough to impact perception of pain, compliance to intervention and/or ability to evaluate treatment outcome as determined by investigator
4. Local infection or other skin disorder at site of surgical incision
5. Pregnancy
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jan Biziel University Hospital No 2 in Bydgoszcz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pawel Sokal
Head of Department of Neurosurgery and Neurology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paweł Sokal
Role: PRINCIPAL_INVESTIGATOR
Jan Biziel University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Neurosurgery and Neurology University Hospital nr 2 Collegium Medicum Nicolaus Copernicus University
Bydgoszcz, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
O'Connell NE, Ferraro MC, Gibson W, Rice AS, Vase L, Coyle D, Eccleston C. Implanted spinal neuromodulation interventions for chronic pain in adults. Cochrane Database Syst Rev. 2021 Dec 2;12(12):CD013756. doi: 10.1002/14651858.CD013756.pub2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JBUH-NN-SCS-2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.